HIK Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Hikma Pharmaceuticals PLC

Watchlist Manager

Watchlist

Price: 1 625 GBX 1.88% Market Closed

Market Cap: £3.4B

	Hikma Pharmaceuticals PLC LSE:HIK	UK
	Siemens AG OTC:SIEGY	DE
L	Logisnext Co Ltd TSE:7105	JP
	Grab Holdings Ltd NASDAQ:GRAB	SG
K	Kroger Co LSE:0JS2	US
B	Benefit Systems SA WSE:BFT	PL
C	Constellation Software Inc F:W9C	CA
	PDD Holdings Inc NASDAQ:PDD	CN
H	Hecla Mining Co SWB:HCL	US
I	Investec PLC DUS:IVKA	UK
A	Alibaba Group Holding Ltd BMV:BABAN	HK

Profitability Summary

Hikma Pharmaceuticals PLC's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

44%

Sustainable 3Y Average Gross Margin

46%

Declining Gross Margin

50% > 44%

Healthy Operating Margin

21%

Sustainable 3Y Average Operating Margin

21%

Declining Operating Margin

23% > 21%

Healthy Net Margin

14%

Sustainable 3Y Average Net Margin

11%

Net Margin is Increasing

5% > 14%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

14% > 6%

Positive ROE

18%

Positive 3Y Average ROE

Positive 3Y Average ROIC

12%

ROIC is Increasing

10% > 12%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.